Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Wednesday, May 31, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
admin
-
May 17, 2023
Latest Pharma-News
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
admin
-
May 17, 2023
Latest Pharma-News
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
admin
-
May 9, 2023
Latest Pharma-News
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
admin
-
May 8, 2023
Latest Pharma-News
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
admin
-
May 8, 2023
Latest Pharma-News
Debiopharm announces launch of galuci study for its Caix-Targeted radiopharmaceutical program
admin
-
March 27, 2023
0
Latest Pharma-News
AZ’s Eplontersen shpows benefit for hereditary transthyretin-mediated amyloid polyneuropathy through 66 weeks
admin
-
March 27, 2023
0
Latest Pharma-News
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis for breast cancer
admin
-
March 27, 2023
0
Latest Pharma-News
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval
admin
-
March 27, 2023
0
Latest Pharma-News
Sandoz receives US FDA approval for biosimilar Hyrimoz® high-concentration formulation
admin
-
March 24, 2023
0
Latest Pharma-News
Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma
admin
-
March 24, 2023
0
Latest Pharma-News
Bayer’s Nubeqa™ approved for additional prostate cancer indication in China
admin
-
March 21, 2023
0
Latest Pharma-News
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
admin
-
March 21, 2023
0
Latest Pharma-News
Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
admin
-
March 20, 2023
0
Latest Pharma-News
FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products
admin
-
March 20, 2023
0
Latest Pharma-News
Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments
admin
-
March 17, 2023
0
Latest Pharma-News
FDA Authorizes Copenhagen Classic Snuff to be Marketed as a Modified Risk Tobacco Product
admin
-
March 17, 2023
0
1
2
3
4
...
143
Page 3 of 143
- Advertisment -
Most Read
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
May 17, 2023
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
May 17, 2023
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
May 9, 2023
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
May 8, 2023